NCT01591330View on ClinicalTrials.gov

A Study of LY2140023 in Healthy Males and Females

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY2140023 Reference form

80-mg tablet administered orally

DRUG

LY2140023 Test-Low

80-mg tablet administered orally

DRUG

LY2140023 Test-Medium

80-mg tablet administered orally

DRUG

LY2140023 Test-High

80-mg tablet administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

Sponsors
All Listed Sponsors
lead

Denovo Biopharma LLC

INDUSTRY

NCT01591330 - A Study of LY2140023 in Healthy Males and Females | Biotech Hunter | Biotech Hunter